Skip to main content
. 2020 Aug 14;28(2):185–197. doi: 10.4103/ipj.ipj_3_19

Table 1.

Sociodemographic details of the sample and comparison across the three treatment groups

Variables Lithium (n=30), n (%) Carbamazepine (n=20), n (%) Sodium valproate (n=17), n (%) df χ2 P
Sex
 Male 16 (53) 14 (70) 13 (76) 2 2.94 0.22
 Female 14 (47) 6 (30) 4 (24)
Religion
 Hindu 24 (80) 16 (80) 14 (82) 2 0.04 0.97
 Muslim 6 (20) 4 (20) 3 (18)
Education
 Illiterate 1 (03) 3 (15) 2 (12) 6 8.41 0.20
 Primary 12 (40) 5 (25) 2 (12)
 High school 17 (57) 11 (55) 13 (76)
 Senior secondary 00 1 (05) 0
Number of past manic episodes
 Nil 26 (87) 16 (80) 11 (66) 6 8.96 0.17
 One 3 (10) 3 (15) 3 (17)
 Two 1 (03) 0 3 (17)
 Three 0 1 (05) 0
Number of past depressive episodes
 Nil 22 (73) 16 (80) 15 (88) 2 1.47 0.47
 One 8 (27) 4 (20) 2 (12)
Family history
 Nil 14 (47) 13 (65) 10 (59) 4 5.96 0.20
 Affective illness 15 (50) 4 (20) 6 (35)
 Nonaffective illness 1 (03) 3 (15) 1 (06)
Type of onset of index episodes
 Abrupt 9 (30) 8 (40) 12 (70) 4 8.84 0.06
 Acute 17 (57) 11 (55) 5 (30)
 Insidious 4 (13) 1 (05) 0
Total number of episodes (including index episodes)
 One 20 (67) 14 (70) 10 (59) 6 7.65 0.26
 Two 7 (23) 5 (25) 3 (18)
 Three 3 (10) 0 4 (23)
 Four 0 1 (05) 0
Antipsychotic drug
 CPZ 21 (70) 15 (75) 16 (94) 2 3.74 0.15
 Haloperidol 9 (30) 5 (25) 1 (06)

df – Degree of freedom; χ2 – Chi-square value; P<0.05; CPZ – Chlorpromazine